0001104659-24-011254.txt : 20240206 0001104659-24-011254.hdr.sgml : 20240206 20240206213045 ACCESSION NUMBER: 0001104659-24-011254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faulkner Robert C. CENTRAL INDEX KEY: 0001831991 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36533 FILM NUMBER: 24601913 MAIL ADDRESS: STREET 1: C/O REDMILE GROUP STREET 2: ONE LETTERMAN DRIVE, BUILDING D, SUITE D CITY: SAN FRANCISCO STATE: CA ZIP: 94129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MedAvail Holdings, Inc. CENTRAL INDEX KEY: 0001402479 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 900772394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4720 E COTTON GIN LOOP STREET 2: SUITE 220 CITY: PHOENIX STATE: AZ ZIP: 85040 BUSINESS PHONE: 1.877.830.0826 MAIL ADDRESS: STREET 1: 4720 E COTTON GIN LOOP STREET 2: SUITE 220 CITY: PHOENIX STATE: AZ ZIP: 85040 FORMER COMPANY: FORMER CONFORMED NAME: MYOS RENS TECHNOLOGY INC. DATE OF NAME CHANGE: 20160322 FORMER COMPANY: FORMER CONFORMED NAME: MYOS Corp DATE OF NAME CHANGE: 20120521 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Therapeutics Corp DATE OF NAME CHANGE: 20100719 4 1 tm245380-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-02 1 0001402479 MedAvail Holdings, Inc. MDVL 0001831991 Faulkner Robert C. C/O REDMILE GROUP, LLC ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129 1 0 0 0 0 Rob Faulkner, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. Effective as of February 2, 2024, Mr. Faulkner resigned from his position as a member of the Issuer's board of directors prior to the Issuer's filing of a voluntary petition for relief under the provisions of Chapter 7 of Title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware. As a result of Mr. Faulkner's resignation, Redmile and Mr. Green have also ceased to be directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. /s/ Robert C. Faulkner 2024-02-06